Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Meta Materials (MMAT) Prices 83.33M Share and Warrant Offering at $0.30/sh
-
Meta Materials Announces Pricing of $25 Million Underwritten Public Offering
-
Meta Materials (MMAT) Announces Proposed Public Offering
-
Meta Materials Announces Proposed Public Offering
-
Cyngn to Participate at the Ladenburg Thalmann Tech Expo 2023
-
Lightwave Logic to Participate in Upcoming Investor Conferences
-
Bitfarms to Participate in the Ladenburg Thalmann Technology Expo 2023
-
Bitfarms to Participate in the Ladenburg Thalmann Technology Expo 2023
-
Saratoga Investment (SAR) Prices $50M Notes Offering
-
Saratoga Investment Corp. Prices Public Offering of $50.0 Million 8.50% Notes Due 2028
-
Saratoga Investment Corp. Prices Public Offering of $50.0 Million 8.50% Notes Due 2028
-
The Mather Group Hires Stuart Evans as Chief Compliance Officer
-
Saratoga Investment (SAR) Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
-
Usio, Inc. to Present at the Ladenburg Thalmann Tech Expo 2023
-
NETSTREIT Corp. (NTST) Announces Daniel Donlan as Chief Financial Officer
-
NETSTREIT Announces Daniel Donlan as Chief Financial Officer
-
Palisade Bio Inc. (PALI) sells 2.27 million shares at $2.64 in direct offering
-
Palisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
-
Bitfarms Mines 424 BTC in March
-
Bitfarms Mines 424 BTC in March
-
Trailblazer Merger Corp. I Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
-
Aptinyx (APTX) Reports Q4, Provides Update on Review of Strategic Alternatives
-
Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives
-
Trailblazer Merger Corporation I Announces Pricing of $60,000,000 Initial Public Offering on Nasdaq
-
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
-
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
-
Ra Medical Systems Announces Closing of $8 Million Private Placement
-
Advisor Group Launches Expanded Access To Liquidity Solutions With New Digital Securities-Based Lending Offering
-
Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
-
Energous Corporation Reports 2022 Fourth-Quarter Results
-
Advisor Group Selects iPipeline® Order Entry Technology to Streamline Annuities for Financial Professionals
-
Sanctuary Wealth Accelerates Growth Strategy with Addition of David Vaughan as Chief Financial Officer
-
Intelligent Bio Solutions (INBS) prices ~570k offering w/warrants at $3.90/share
-
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
-
Intelligent Bio Solutions (INBS) Announces Proposed Public Offering
-
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
-
Form X-17A-5 LADENBURG THALMANN & For: Dec 31
-
Apexigen (APGN) Announces Review of Strategic Alternatives and Restructuring
-
Apexigen Announces Review of Strategic Alternatives and Restructuring
-
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
-
U.S. inflation accelerates in January, consumer spending surges
-
Aileron Therapeutics (ALRN) Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial, Explores Strategic Alternatives
-
Aileron Therapeutics (ALRN) Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
-
Essential Properties Realty Trust (EPRT) Prices Upsized 7.7M Share Offerings at $24.60/sh
-
Essential Properties Realty Trust, Inc. Announces Pricing of Upsized Public Offering of Common Stock
-
Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change

